Harmonization of distributed multi‐center analysis based on dried blood spot reference materials supporting the screening of neonatal inherited metabolic disorders

Shou‐Fang Qu,Hao‐Ran Tao,Liu‐Ji Qin,Wen‐Xin Zhang,Shan Han,Shen‐Yan Zhang,Jie Huang
DOI: https://doi.org/10.1002/jcla.24970
IF: 3.124
2023-10-15
Journal of Clinical Laboratory Analysis
Abstract:The flowchart outlines our research process. A range of evaluations were carried out after the development of DBS reference materials, which are applicable to correct the results of diverse laboratories, kits and platforms. We anticipate our products will ensure dependable harmonization and standardization for multi‐center metabolism analysis in the future. Background The standardization of quantification data is critical for ensuring the reliability and measurement traceability in the screening of neonatal inherited metabolic disorders. However, the availability of national certified reference materials is limited in China. Methods In this study, we developed a series of dried blood spot (DBS) reference materials containing 9 amino acids (AA) and 10 acylcarnitines (AC) for neonatal screening. Four levels of the reference materials were measured with tandem mass spectrometry (MS/MS) by seven laboratories using different commercial In Vitro Diagnostic Device (IVD) kits. Then, 100 clinical samples were measured using both derivatization and non‐derivatization methods by the same laboratory. Results We found high homogeneity and stability at all levels of the reference materials, with the coefficient of variation (CV) of the analytes less than 15%. These reference materials can be used to assess the testing capabilities of different laboratories. Our test also revealed that the correction factors (CF) calculated by the reference materials, along with clinical samples, could increase the consistency for different kits. Conclusion The DBS reference materials proposed in this study provide reliability for the harmonization in multi‐center analysis for the screening of neonatal inherited metabolic disorders. And applying our correction method for the screening could improve the data consistency of the DBS samples prepared by different methods.
medical laboratory technology
What problem does this paper attempt to address?